[ Price : $8.95]
FDA gives investigative device exemption approval for an Aqua Medical pilot clinical trial of its Proximal Intestinal Mucosal Abla...[ Price : $8.95]
A new report from the Reagan-Udall Foundation calls for broad operational and policy reforms to improve the efficiency, representa...[ Price : $8.95]
Sydnexis says its SYD-101 drug to treat pediatric progressive myopia met both the primary and key secondary endpoints in the Phase...[ Price : $8.95]
FDA approves a Meitheal Pharmaceuticals NDA for Contepo (fosfomycin) for injection for treating adults with complicated urinary tr...[ Price : $8.95]
FDA lifts a clinical hold against the Rein Therapeutics Phase 2 RENEW trial evaluating LTI-03 in patients with idiopathic pulmonar...[ Price : $8.95]
Aurinia Pharmaceuticals lawsuit against CDER director George Tidmarsh includes screenshots of troubling text messages and emails f...[ Price : $8.95]
CDER director George Tidmarsh resigns after being placed on administrative leave amid an internal ethics investigation and a defam...[ Price : $8.95]
FDA approves UCBs Kygevvi (doxecitine and doxribtimine) for treating thymidine kinase 2 deficiency.